MUMBAI, (IANS) – Pharma major Lupin Limited has said that it has launched Mirabegron extended-release tablets, 25 mg, in the US market, after having received approval from the Food and Drug Administration. Mirabegron Extended-Release Tablets, 25 mg is a generic equivalent of Myrbetriq®Extended-Release Tablets, 25 […] Read this story
